Fig. 1
From: Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
The deployment of hydrogels in doxorubicin delivery. The hydrogels are able to co-deliver doxorubicin with other genes or drugs to mediate synergistic tumor suppression. Moreover, the stimuli-responsive hydrogels can increase the specific release of doxorubicin at the tumor site to enhance cancer suppression. The development of hydrogels from natural polymers including chitosan, gelatin and alginate can improve biocompatibility and biodegradability in the cancer therapy and doxorubicin release. Doxorubicin can be loaded on nanoparticles and incorporate into the hydrogels to improve sustained release of doxorubicin in cancer chemotherapy (Biorender.com)